Showing 161 - 170 of 776
Persistent link: https://www.econbiz.de/10000693491
Persistent link: https://www.econbiz.de/10000693669
Persistent link: https://www.econbiz.de/10000695140
Persistent link: https://www.econbiz.de/10000695365
Persistent link: https://www.econbiz.de/10000696121
Persistent link: https://www.econbiz.de/10000696162
Persistent link: https://www.econbiz.de/10000696736
Persistent link: https://www.econbiz.de/10000696744
To assess the efficacy of Covid-19 non-pharmaceutical interventions (NPIs) on infectious disease containment in Europe, we first use weekly 2015-20 data on the spread of influenza and respiratory syncytial virus (RSV) to compare the 2019-20 season of these diseases with the previous five....
Persistent link: https://www.econbiz.de/10012497828
The COVID-19 pandemic has forced countries to make difficult ethical choices, e.g., how to balance public health and socioeconomic activity and whom to prioritize in allocating vaccines or other scarce medical resources. We discuss the implications of benefit-cost analysis, utilitarianism, and...
Persistent link: https://www.econbiz.de/10012597327